Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 2883B 凱基金乙特. Please read: https://finlab.finance/en/setup?stock=2883B

2883B

凱基金乙特 Other Securities As of 2026-07-28 Updated daily after market close

2 signals active.

This page refreshes daily after the close. Add 凱基金乙特 to your watchlist to track signal changes on your next visit.
估值 50品質 50成長 50動能 63籌碼 96

Is 凱基金乙特 a buy? Fundamentals and valuation first

  • 外資近期偏買。外資近 20 日買賣超約佔成交量 18.5%(買超)。

Chip flow

Bullish +0.97
BearishNeutralBullish

Single-sided accumulation, concentration rising — bullish

  • Single-sided accumulation, concentration rising — bullish
  • 凱基 holds 15,544 lots
  • sellers have 798 lots left, ~109 sessions to clear

Window from 2026-01-17 · Price +5% · branches to 2026-06-17· TDCC to 2026-06-12

  • Largest holder 凱基 has accumulated 15,544 lots since the start (sold 0%), holding.
  • Main distributor 台灣摩根士丹利 peaked at 1,463 lots, has sold 37%, 916 left, paused recently.
  • TDCC big holders (absolute) >1000-lot holders +3.01pp, mid holders -25, retail -1.98pp — concentration shifting upward.
  • Foreign hedge-desk net short Net short -2,763 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
凱基元大-北三重元大證券統一富邦證券國泰證券
Distributing
台灣摩根士丹利國票證券美林台新-中港凱基-大安統一-基隆
Desks
own scale
新光台新證券凱基-竹科元大-金華
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 凱基 +15,544
    sold 0%
  • 元大-北三重 +12,297
    sold 0%· still adding
  • 元大證券 +5,825
    sold 0%
  • 統一 +5,216
    sold 0%
  • 富邦證券 +5,070
    sold 0%· still adding
  • 國泰證券 +3,754
    sold 0%

Distributing

  • 台灣摩根士丹利 916 left
    sold 37%· paused recently
  • 國票證券 264 left
    sold 78%· paused recently
  • 美林 569 left
    sold 46%· ~109 sessions to clear
  • 台新-中港 283 left
    sold 72%· paused recently
  • 凱基-大安 206 left
    sold 68%· paused recently
  • 統一-基隆 212 left
    sold 46%· ~25 sessions to clear

Desks

  • 新光 -4,514
    unclassified
  • 台新證券 -3,914
    unclassified
  • 凱基-竹科 -2,265
    unclassified
  • 元大-金華 -2,035
    unclassified
Still selling 798 lots ~109 sessions to bottom at most
Recent buy/sell force +3,900 absorbed / -140 sold buyers slightly ahead
Hedge-desk net short -1,041 lots potential cover-buying, not selling pressure
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Direction matches: big-holder share rose while retail share fell.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

目前正在發生的訊號

以下訊號在最近一筆資料中成立,附這檔股票自身歷史上每次出現後的前瞻報酬統計

股價創 252 日新高(突破日)

Active

還原股價首次站上過去 252 個交易日最高;20 日內重複觸發只計一次

8 historical occurrences (since 2024-09-19)
Average forward return after 股價創 252 日新高(突破日)。20-day: Win 57.1%, Sample 7, Median +0.52%, Excess -2.14%, Beat mkt rate 28.6%;60-day: Win 57.1%, Sample 7, Median +1.24%, Excess -13.46%, Beat mkt rate 14.3%;120-day: Win 100%, Sample 5, Median +1.94%, Excess -22.6%, Beat mkt rate 20%

120 days after: historical avg +3.34%

20-day +0.37%
60-day +0.59%
120-day +3.34%
20-day
60-day
120-day
Win
57.1%
57.1%
100%
Sample
7
7
5
Median
+0.52%
+1.24%
+1.94%
Excess
-2.14%
-13.46%
-22.6%
Beat mkt rate
28.6%
14.3%
20%

Over 5 occurrences, 120-day forward avg gained 3.34%, lagged the market by 22.6 pts; win rate 100%.

外資連續買超滿 5 個交易日

Active · now 10%

外資(不含自營商)買賣超連續 5 日為正,事件日為第 5 日;20 日內重複觸發只計一次

8 historical occurrences (since 2024-06-21)
Average forward return after 外資連續買超滿 5 個交易日。20-day: Win 57.1%, Sample 7, Median +0.62%, Excess -2.34%, Beat mkt rate 57.1%;60-day: Win 85.7%, Sample 7, Median +2.37%, Excess -9.16%, Beat mkt rate 42.9%;120-day: Win 100%, Sample 5, Median +7.43%, Excess -9.36%, Beat mkt rate 60%

120 days after: historical avg +5.61%

20-day +0.09%
60-day +2.17%
120-day +5.61%
20-day
60-day
120-day
Win
57.1%
85.7%
100%
Sample
7
7
5
Median
+0.62%
+2.37%
+7.43%
Excess
-2.34%
-9.16%
-9.36%
Beat mkt rate
57.1%
42.9%
60%

Over 5 occurrences, 120-day forward avg gained 5.61%, lagged the market by 9.36 pts; win rate 100%.

這個訊號在全市場是否站得住腳

「月營收年增率 ≥ 20%」過去 243 個月,每月平均約 404 檔個股符合條件;這些個股之後 60 個交易日的還原股價報酬,等權平均為 6.99%,平均贏過大盤 2.32 個百分點,在 64.2% 的月份中跑贏發行量加權股價報酬指數。

每月對全市場符合訊號的股票取等權平均前瞻 60 日還原報酬,再對月份平均;超額相對發行量加權股價報酬指數

What does 凱基金乙特 do? Company profile

金融保險業/金控業特別股 臺灣證券交易所上市

Overview

2883B 為凱基金融控股股份有限公司乙種特別股,非普通股營運公司。發行人為凱基金融控股股份有限公司,原名中華開發金融控股股份有限公司,成立與上市日期均為 2001/12/28,總部位於台北市松山區敦化北路135號8、12、13及18樓;董事長王銘陽、總經理楊文鈞;實收資本額約新台幣1,855.7億元,普通股代號2883,主要業務為投資及被投資公司之管理。2883B 係 2021/12/30 因受讓中國人壽股份轉換而增發上市之乙種特別股,原簡稱開發金乙特,2024/10/11 隨公司更名後簡稱變更為凱基金乙特;更名換發後公告之上市特別股數量為1,582,142,374股。此證券無追蹤指數、無 ETF 成分股、無權證標的結構;其核心條款為發行價格每股新台幣10元、特別股股息初始年率3.55%(七年期IRS利率0.75%加2.80%),七年期IRS利率於發行日起滿七年後及其後每七年重設。

Business

2883B 本身不從事營運,投資人承擔的是凱基金控乙種特別股的股息、收回、利率重設與發行人信用/資本適足風險。其股息每年以現金一次發放,但公司對特別股股息分派具自主裁量權;若年度決算無盈餘、盈餘不足、發放後資本適足率低於法令或主管機關要求,或基於其他必要考量,公司得決議不分派。此特別股為非累積型,未分派或不足額股息不遞延補發;特別股股東除約定股息外,不參加普通股盈餘或資本公積分派。剩餘財產分派順序優先於普通股,但以不超過發行金額為限;原則上無表決權及選舉權,但於特別股股東會及涉及特別股權利義務事項有表決權;不得轉換普通股;無到期日,股東無權要求公司收回,公司於發行日起屆滿七年後得按實際發行價格收回全部或一部。發行人凱基金控旗下主要事業體包括凱基人壽、凱基銀行、凱基證券、凱基投信與中華開發資本,業務涵蓋壽險、銀行、證券、資產管理與私募股權/投資管理。

Outlook 2025–2028

此為非營運特別股,沒有產品擴產或營收成長展望;2025至2028年的核心觀察點在於發行人凱基金控的可分配盈餘、資本適足率、壽險投資收益與避險成本、銀行與證券獲利,以及2028年前後七年期IRS利率重設與公司是否行使收回權。已查得凱基金控公告2025全年稅後淨利新台幣300億元、EPS 1.74元,凱基人壽2025年稅後淨利158億元,銀行與證券雙位數成長,且公司表示將延續穩健股利政策;這對特別股配息能力屬正面訊號,但不構成保證。2026年起 IFRS 17 與保險資本制度接軌,使壽險商品結構、CSM存量、匯率避險與外匯價格變動準備金更影響金控獲利與資本水位。主要風險包括:新台幣大幅升值推升避險成本、股債市場波動侵蝕壽險投資收益、資本適足率或法規要求限制配息、非累積條款導致停配年度不補發、利率重設後股息率不確定、以及公司未必於可收回時點收回。

Sources(10)

This company profile is compiled from public sources (annual reports, filings, news and analyst reports), not finlab backtest data; the 2025–2028 outlook contains forward-looking estimates and is for reference only.

方法與限制

  • 所有報酬以還原股價(etl:adj_close)計算,已還原除權息與股票分割。
  • 超額報酬以發行量加權股價報酬指數(含息)為基準。
  • 估值位階與分位統計以「截至當天為止的自身歷史」滾動計算,不使用未來資訊。
  • 營收訊號的事件日對齊到公告截止日後第一個交易日,避免提前用到尚未公開的資訊。
  • 事件樣本之間日期可能重疊,統計僅描述歷史分布,樣本數較少時參考價值有限。

本頁內容為歷史資料統計與教育用途,不構成投資建議。投資一定有風險,過去績效不代表未來表現,交易前請自行評估並承擔風險。